𝔖 Bobbio Scriptorium

✦ LIBER ✦

A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

✍ Scribed by Goss, Paul E.; Ingle, James N.; Martino, Silvana; Robert, Nicholas J.; Muss, Hyman B.; Piccart, Martine J.; Castiglione, Monica; Tu, Dongsheng; Shepherd, Lois E.; Pritchard, Kathleen I.; Livingston, Robert B.; Davidson, Nancy E.; Norton, Larry; Perez, Edith A.; Abrams, Jeffrey S.; Therasse, Patrick; Palmer, Michael J.; Pater, Joseph L.

Book ID: 121001006
Publisher: Massachusetts Medical Society
Year: 2003
Tongue: English
Weight: 219 KB
Volume: 349
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa032312

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Benefit of Letrozole in Postmenopausal

A Benefit of Letrozole in Postmenopausal Women After Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

✍ Heather DeGrendele; Joyce A. O'Shaughnessy 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 94 KB

3–52 A Comparison of Letrozole and Tamox

3–52 A Comparison of Letrozole and Tamoxifen in Postmenopausal Women With Early Breast Cancer

✍ Haley, B.B. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 86 KB

1–42 A Randomized Trial of Exemestane Af

1–42 A Randomized Trial of Exemestane After Two to Three Years of Tamoxifen Therapy in Postmenopausal Women With Primary Breast Cancer

✍ Buzdar, A.U. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Cost-Effectiveness of Letrozole Versus T

Cost-Effectiveness of Letrozole Versus Tamoxifen as Initial Adjuvant Therapy in Hormone Receptor–Positive Postmenopausal Women with Early-Stage Breast Cancer

✍ Thomas E. Delea; Jon Karnon; Oleg Sofrygin; Simu K. Thomas; Natalie L. Papo; Vic 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 194 KB

Randomized trial of two versus five year

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer: Swedish Breast Cancer Cooperative Group J Natl Cancer Inst 1996:88:1543-49

📂 Article 📅 1997 🏛 Elsevier Science 🌐 French ⚖ 224 KB

Randomised trial of two versus five year

Randomised trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer: preliminary results of the SITAM-01

✍ M. Sacco; M. Valentini; M. Belfiglio; A. Nicolucci; F. Pellegrini 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 141 KB